Michelle Archer
Impact in
- Pharmaceutical Science top 10%
- Drug Solubulity and Delivery Systems
- Advanced Drug Delivery Systems
- Infectious Diseases top 10%
- SARS-CoV-2 and COVID-19 Research
Papers in
-
- Protein purification and stability 2
- RNA Interference and Gene Delivery 2
-
- SARS-CoV-2 and COVID-19 Research 2
- Tuberculosis Research and Epidemiology 1
- Co-authors
- Ryan M. Kramer (8 shared papers)Christopher B. Fox (8 shared papers)Elise Larson (2 shared papers)Neal Van Hoeven (2 shared papers)Alana Gerhardt (4 shared papers)Emily Gage (1 shared paper)Dan T. Stinchcomb (1 shared paper)Jesse H. Erasmus (1 shared paper)
- Journals
- Molecular Therapy — Methods & Clinical Development (1 paper)AAPS PharmSciTech (1 paper)Heliyon (1 paper)European Journal of Pharmaceutics and Biopharmaceutics (1 paper)Molecular Therapy (1 paper)
- Partner nations
- United StatesCanada
In The Last Decade
Michelle Archer
8 papers receiving 306 citations
Peers
Comparison fields: 5 of 52
- Pharmaceutical Science 51
- Infectious Diseases 109
- Immunology 92
- Molecular Biology 156
- Animal Science and Zoology 21
Countries citing papers authored by Michelle Archer
This map shows the geographic impact of Michelle Archer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle Archer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle Archer more than expected).
Fields of papers citing papers by Michelle Archer
This network shows the impact of papers produced by Michelle Archer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle Archer. The network helps show where Michelle Archer may publish in the future.
Co-authors
The 25 scholars most cited alongside Michelle Archer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 123 | |
| 2 | 2022 | 61 | |
| 3 | 2020 | 41 | |
| 4 | 2018 | 38 | |
| 5 | 2018 | 30 | |
| 6 | 2021 | 21 | |
| 7 | 2016 | 4 | |
| 8 | 2023 | 1 |
About Michelle Archer
Michelle Archer is a scholar working on Molecular Biology, Infectious Diseases, Pharmaceutical Science, Pulmonary and Respiratory Medicine and Food Science, having authored 8 papers that have together received 319 indexed citations. Recurring topics across this work include Drug Solubulity and Delivery Systems (3 papers), Inhalation and Respiratory Drug Delivery (2 papers), Microencapsulation and Drying Processes (2 papers), Protein purification and stability (2 papers), RNA Interference and Gene Delivery (2 papers), SARS-CoV-2 and COVID-19 Research (2 papers), Tuberculosis Research and Epidemiology (1 paper) and Hepatitis B Virus Studies (1 paper). The work is most often cited by research in Pharmaceutical Science (51 citations), Infectious Diseases (109 citations), Immunology (92 citations), Molecular Biology (156 citations) and Animal Science and Zoology (21 citations). Michelle Archer has collaborated with scholars based in United States and Canada. Frequent co-authors include Ryan M. Kramer, Christopher B. Fox, Elise Larson, Neal Van Hoeven, Alana Gerhardt, Emily Gage, Dan T. Stinchcomb, Jesse H. Erasmus, Jacob Archer and Rhea N. Coler. Their work appears in journals such as Molecular Therapy — Methods & Clinical Development, AAPS PharmSciTech, Heliyon, European Journal of Pharmaceutics and Biopharmaceutics and Molecular Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.